18553

    543980

    JLHL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    JUPITER LIFE LINE HOSP L Share Price Today

    JUPITER LIFE LINE HOSP L is currently trading at ₹1565.3, down by ₹1.79 from the previous close. The stock touched an intraday high of ₹1591.00 and a low of ₹1542.10 during the latest trading session. Over the past one year, JUPITER LIFE LINE HOSP L has delivered a return of 6.41%, while the stock has gained 15.44% in the last one month.

    JUPITER LIFE LINE HOSP L performance

    Today’s low Today’s high
    ₹ 1542.10 ₹ 1591.00
    ₹ 1561.30
    52 week low 52 week high
    ₹ 1178.00 ₹ 1625.00
    ₹ 1561.30
    Open Price ₹ 1567.20
    Prev. Close ₹ 1567.10
    Volume (Shares) 42347.00
    Total traded value ₹ 661.16
    Upper Circuit ₹ 1880.50
    Lower Circuit ₹ 1253.70
    info

    Investment Returns

    Over 1 Month 15.44% Over 3 Months 21.39% Over 6 Months 18.34% Over 1 Year 6.41%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    JUPITER LIFE LINE HOSP L fundamentals


    • Market cap (Cr) 10,228.30
    • P/E Ratio (TTM) 53.68
    • Beta 0.30
    • Book Value / share 245.18
    • Return on equity 12.63%
    • EPS (TTM) 27.89
    • Dividend yield 0.06%
    • Net profit/quarter (Cr) 49.20
    info icon alternate text
    • Market cap (Cr) 10,246.70
    • P/E Ratio (TTM) 53.68
    • Beta 0.27
    • Book Value / share 245.18
    • Return on equity 12.63%
    • EPS (TTM) 27.89
    • Dividend yield 0.06%
    • Net profit/quarter (Cr) 49.20
    info icon alternate text

    JUPITER LIFE LINE HOSP L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 312.42
    Operating Expense 256.98
    Net Profit 49.20
    Net Profit Margin (%) 15.74
    Earnings Per Share (EPS) 7.51
    EBITDA 88.23
    Effective Tax Rate (%) 24.93
    Particulars DEC 2025 (Values in Cr)
    Revenue 291.40
    Operating Expense 235.26
    Net Profit 44.28
    Net Profit Margin (%) 15.19
    Earnings Per Share (EPS) 6.75
    EBITDA 79.22
    Effective Tax Rate (%) 25.90
    Particulars SEP 2025 (Values in Cr)
    Revenue 315.82
    Operating Expense 256.64
    Net Profit 54.60
    Net Profit Margin (%) 17.28
    Earnings Per Share (EPS) 8.33
    EBITDA 90.12
    Effective Tax Rate (%) 22.53
    Particulars JUN 2025 (Values in Cr)
    Revenue 277.99
    Operating Expense 230.07
    Net Profit 43.29
    Net Profit Margin (%) 15.57
    Earnings Per Share (EPS) 6.60
    EBITDA 80.42
    Effective Tax Rate (%) 28.74
    Particulars MAR 2025 (Values in Cr)
    Revenue 273.77
    Operating Expense 219.08
    Net Profit 44.45
    Net Profit Margin (%) 16.23
    Earnings Per Share (EPS) 6.78
    EBITDA 79.16
    Effective Tax Rate (%) 28.05
    Particulars MAR 2026 (Values in Cr)
    Revenue 1197.62
    Operating Expense 978.96
    Net Profit 191.38
    Net Profit Margin (%) 15.98
    Earnings Per Share (EPS) 29.19
    EBITDA 338.01
    Effective Tax Rate (%) 25.39
    Particulars MAR 2025 (Values in Cr)
    Revenue 1060.07
    Operating Expense 841.80
    Net Profit 184.70
    Net Profit Margin (%) 17.42
    Earnings Per Share (EPS) 28.17
    EBITDA 297.36
    Effective Tax Rate (%) 25.02
    Particulars MAR 2024 (Values in Cr)
    Revenue 914.57
    Operating Expense 736.44
    Net Profit 151.95
    Net Profit Margin (%) 16.61
    Earnings Per Share (EPS) 24.89
    EBITDA 253.00
    Effective Tax Rate (%) 25.44
    Particulars MAR 2023 (Values in Cr)
    Revenue 787.32
    Operating Expense 639.61
    Net Profit 107.21
    Net Profit Margin (%) 13.61
    Earnings Per Share (EPS) 20.58
    EBITDA 215.20
    Effective Tax Rate (%) 32.52
    Particulars MAR 2022 (Values in Cr)
    Revenue 657.28
    Operating Expense 555.32
    Net Profit 84.67
    Net Profit Margin (%) 12.88
    Earnings Per Share (EPS) 16.65
    EBITDA 162.60
    Effective Tax Rate (%) 19.90
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 235.50
    ROE % 13.39
    ROCE % 15.01
    Total Debt to Total Equity 0.34
    EBITDA Margin 25.39
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 206.85
    ROE % 15.34
    ROCE % 18.51
    Total Debt to Total Equity 0.16
    EBITDA Margin 25.22
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 178.30
    ROE % 23.02
    ROCE % 22.10
    Total Debt to Total Equity 0.31
    EBITDA Margin 24.61
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 64.70
    ROE % 22.12
    ROCE % 21.07
    Total Debt to Total Equity 1.46
    EBITDA Margin 23.48
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 57.36
    ROE % 19.20
    ROCE % 16.66
    Total Debt to Total Equity 1.73
    EBITDA Margin 21.45
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 245.18
    ROE % 12.63
    ROCE % 15.25
    Total Debt to Total Equity 0.16
    EBITDA Margin 28.22
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 216.96
    ROE % 13.85
    ROCE % 18.06
    Total Debt to Total Equity 0.05
    EBITDA Margin 28.05
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 189.92
    ROE % 17.77
    ROCE % 22.13
    Total Debt to Total Equity 0.17
    EBITDA Margin 27.66
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 82.28
    ROE % 27.01
    ROCE % 26.40
    Total Debt to Total Equity 0.78
    EBITDA Margin 27.33
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 64.30
    ROE % 29.09
    ROCE % 23.16
    Total Debt to Total Equity 1.00
    EBITDA Margin 24.74
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 58.16
    Total Assets 2383.12
    Total Liabilities 2383.12
    Total Equity 1544.09
    Share Outstanding 6
    Price to Book Ratio 5.19
    Return on Assets (%) 8.14
    Return on Capital (%) 9.45
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 94.98
    Total Assets 1935.75
    Total Liabilities 1935.75
    Total Equity 1356.30
    Share Outstanding 6
    Price to Book Ratio 7.34
    Return on Assets (%) 9.98
    Return on Capital (%) 11.49
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 301.25
    Total Assets 1281.33
    Total Liabilities 1281.33
    Total Equity 1168.73
    Share Outstanding 6
    Price to Book Ratio 6.31
    Return on Assets (%) 13.78
    Return on Capital (%) 15.11
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 134.46
    Total Assets 985.53
    Total Liabilities 985.53
    Total Equity 363.91
    Share Outstanding 5
    Price to Book Ratio 0.00
    Return on Assets (%) 7.39
    Return on Capital (%) 8.76
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 103.36
    Total Assets 908.69
    Total Liabilities 908.69
    Total Equity 288.43
    Share Outstanding 5
    Price to Book Ratio 0.00
    Return on Assets (%) 5.62
    Return on Capital (%) 6.52
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 40.82
    Total Assets 2160.27
    Total Liabilities 2160.27
    Total Equity 1607.55
    Share Outstanding 6
    Price to Book Ratio 5.19
    Return on Assets (%) 8.85
    Return on Capital (%) 10.24
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 86.99
    Total Assets 1717.59
    Total Liabilities 1717.59
    Total Equity 1422.54
    Share Outstanding 6
    Price to Book Ratio 7.34
    Return on Assets (%) 10.75
    Return on Capital (%) 12.33
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 297.19
    Total Assets 1360.59
    Total Liabilities 1360.59
    Total Equity 1245.25
    Share Outstanding 6
    Price to Book Ratio 6.31
    Return on Assets (%) 11.16
    Return on Capital (%) 12.2
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 133.30
    Total Assets 885.33
    Total Liabilities 885.33
    Total Equity 465.02
    Share Outstanding 5
    Price to Book Ratio 0.00
    Return on Assets (%) 12.10
    Return on Capital (%) 14.06
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 102.15
    Total Assets 754.74
    Total Liabilities 754.74
    Total Equity 328.87
    Share Outstanding 5
    Price to Book Ratio 0.00
    Return on Assets (%) 11.21
    Return on Capital (%) 13.01
    Particulars MAR 2026 (Values in Cr)
    Net Income 265.32
    Cash from Operations 331.57
    Cash from Investing -441.93
    Cash from Financing 136.46
    Net change in Cash -37.75
    Free Cash Flow 833.41
    Particulars MAR 2025 (Values in Cr)
    Net Income 260.67
    Cash from Operations 330.94
    Cash from Investing -497.33
    Cash from Financing 296.70
    Net change in Cash 66.11
    Free Cash Flow 658.52
    Particulars MAR 2024 (Values in Cr)
    Net Income 195.41
    Cash from Operations 164.20
    Cash from Investing -246.14
    Cash from Financing 128.15
    Net change in Cash -3.46
    Free Cash Flow 249.49
    Particulars MAR 2023 (Values in Cr)
    Net Income 128.70
    Cash from Operations 195.88
    Cash from Investing -94.24
    Cash from Financing -51.05
    Net change in Cash 31.09
    Free Cash Flow 273.12
    Particulars MAR 2022 (Values in Cr)
    Net Income 77.11
    Cash from Operations 145.59
    Cash from Investing -85.24
    Cash from Financing 32.20
    Net change in Cash 83.92
    Free Cash Flow 237.32
    Particulars MAR 2026 (Values in Cr)
    Net Income 260.92
    Cash from Operations 289.98
    Cash from Investing -423.40
    Cash from Financing 145.44
    Net change in Cash -47.10
    Free Cash Flow 773.17
    Particulars MAR 2025 (Values in Cr)
    Net Income 246.34
    Cash from Operations 281.03
    Cash from Investing -454.92
    Cash from Financing 301.83
    Net change in Cash 65.55
    Free Cash Flow 561.44
    Particulars MAR 2024 (Values in Cr)
    Net Income 203.82
    Cash from Operations 159.47
    Cash from Investing -238.03
    Cash from Financing 121.88
    Net change in Cash -6.36
    Free Cash Flow 235.82
    Particulars MAR 2023 (Values in Cr)
    Net Income 158.88
    Cash from Operations 217.32
    Cash from Investing -129.65
    Cash from Financing -23.22
    Net change in Cash 31.14
    Free Cash Flow 260.58
    Particulars MAR 2022 (Values in Cr)
    Net Income 105.71
    Cash from Operations 150.96
    Cash from Investing -68.92
    Cash from Financing 9.66
    Net change in Cash 83.08
    Free Cash Flow 217.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8920.60 65.57 13.54 128264.54 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.64 22.91 2.76 94.91 40.75 76.00
    SHREE PACETRONIX LTD. 139.40 16.63 2.93 52.27 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.04 0.00 2.74 23.03 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8920.60 85.44 12.87 128264.54 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.84 0.00 -9.20 28.27 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5932.05 26.55 4.91 6489.66 5010.00 6725.00

    JUPITER LIFE LINE HOSP L shareholding pattern

    Holding
    33.2%
    40.91%
    9.36%
    16.51%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    JUPITER LIFE LINE HOSP L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1560.00 -0.45 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 1543.60
    • 26 Days 1451.10
    • 10 Days 1514.50
    • 50 Days 1399.60
    • 12 Days 1504.40
    • 100 Days 1362.90
    • 20 Days 1470.70
    • 200 Days 1366.60
    1563.67 PIVOT
    First Support 1553.63 First Resistance 1577.13 Second Support 1540.17 Second Resistance 1587.17 Third Support 1530.13 Third Resistance 1600.63
    RSI 85.01 ADX 61.52 MACD 53.30 Williams % R -9.42 Commodity Channel Index (CCI) 160.25
    Date 2026-07-21 Week 25632.00 Same Day 12571.00 Month 25842.00
    1 Year 0.31 3 Year 0.39
    Over 1 Month
    15.44% down
    Over 1 Year
    6.41% down
    Over 3 Months
    21.39% down
    Over 3 Years
    13.36% down
    Over 6 Months
    18.34% down
    Over 5 Years
    0.00% down

    JUPITER LIFE LINE HOSP L Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    22 May 2026 1.0 Interim 22 May 2026 Equity shares
    04 Jul 2025 1.0 Final 04 Jul 2025 Equity shares
    02 Aug 2024 1.0 Final 02 Aug 2024 Equity shares
    Ex-Date Old FV NEW FV Record Date
    24 Jul 2026 10.0 2.0 24 Jul 2026
    Dividend date Dividend amount Dividend type Record date Instrument type
    22 May 2026 1.0 Interim 22 May 2026 Equity shares
    04 Jul 2025 1.0 Final 04 Jul 2025 Equity shares
    02 Aug 2024 1.0 Final 02 Aug 2024 Equity shares
    Ex-Date Old FV NEW FV Record Date
    24 Jul 2026 10.0 2.0 24 Jul 2026

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Jupiter Life Line Hospitals Ltd?

    Answer Field

    Jupiter Life Line Hospitals Ltd share price is for NSE ₹ 1,565.30 & for BSE ₹ 1,565.00 as on Jul 22 2026 03:29 PM.

    What is the Market Cap of Jupiter Life Line Hospitals Ltd Share?

    Answer Field

    The market cap of Jupiter Life Line Hospitals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 22 2026 03:29 PM.

    What is the 52 Week High and Low of Jupiter Life Line Hospitals Ltd?

    Answer Field

    The 52 Week High and Low of Jupiter Life Line Hospitals Ltd for NSE is ₹ 1,625.00 and ₹ 1,178.00 and for BSE is ₹ 1,618.15 and ₹ 1,152.05.

    What is 1 year return for Jupiter Life Line Hospitals Ltd?

    Answer Field

    The 1 year returns on the stock has been 6.41%.

    What is the P/E Ratio of Jupiter Life Line Hospitals Ltd Share?

    Answer Field

    As on Jul 22 2026 03:29 PM the price-to-earnings (PE) ratio for Jupiter Life Line Hospitals Ltd share is 53.68.

    What is the PB ratio of Jupiter Life Line Hospitals Ltd Share?

    Answer Field

    As on Jul 22 2026 03:29 PM, the price-to-book (PB) ratio for Jupiter Life Line Hospitals Ltd share is 245.18.

    How to Buy Jupiter Life Line Hospitals Ltd Share?

    Answer Field

    You can trade in Jupiter Life Line Hospitals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Jupiter Life Line Hospitals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Jupiter Life Line Hospitals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Jupiter Life Line Hospitals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |